NCT03125057View on ClinicalTrials.gov

A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 2, 2017

Primary Completion Date

May 10, 2020

Study Completion Date

May 10, 2020

Conditions
Port-wine Stain
Interventions
DRUG

Hemoporfin PDT

Photodynamic therapy is performed using hemoporfin. Hemoporfin（5mg/kg）is infused for 20 minutes, followed by light illumination at 10 minutes from the start of infusion. Different light dose of PDT is applied to the patients.

Trial Locations (1)

100045

Beijing Children's Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

INDUSTRY

NCT03125057 - A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain | Biotech Hunter | Biotech Hunter